Thyroxine/Liothyronine

甲状腺素/碘塞罗宁

Report date: 2022/01/14 13:23:58

Base Information

Drug NameThyroxine/Liothyronine
Drug Alias NameThyroxine-Liothyronine mixt甲状腺素-碘塞罗宁Thyroxine and Liothyronine甲状腺素●碘塞罗宁Thyroxine●Liothyronine +[13] 
ClassificationSmall molecules
Mechanisms of ActionThyroid hormone receptor beta-1 agonistsThyroid hormone receptor alpha agonists
TargetsThyroid hormone receptor betaThyroid hormone receptor alpha
Therapy Area/IndicationsCataract
Global Approved IndicationsCataract
Approved Indications in ChinaCataract
Original Approved Country/TerritoryMainland China
Original Approved Date2005/01/13
Country/TerritoryMainland China
CombinationsYes Liothyronine sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Wujing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Wujing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCataract
Inactive IndicationsN/A

Other Information

ATC CodeH03AA03
Related LinksN/A